DNTH

21.55

0.69% -0.15

Handel nachbörslich: 21.51 -0.04 -0.19%

Dianthus Therapeutics Inc (DNTH)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$21.70

Offen:

$21.76

24-Stunden-Volumen:

176.97K

Relative Volume:

0.55

Marktkapitalisierung:

$689.10M

Einnahmen:

$4.12M

Nettoeinkommen (Verlust:

$-56.68M

KGV:

-3.8879

EPS:

-5.5429

Netto-Cashflow:

$-51.44M

1W Leistung:

+0.47%

1M Leistung:

+33.68%

6M Leistung:

-25.04%

1J Leistung:

-16.47%

1-Tages-Spanne:

$20.11

$22.12

1-Wochen-Bereich:

$20.11

$22.30

52-Wochen-Spanne:

$13.37

$32.27

Dianthus Therapeutics Inc Stock (DNTH) Company Profile

Firmenname

Dianthus Therapeutics Inc

Sektor

Healthcare (1150)

Branche

Biotechnology (676)

Telefon

929-999-4055

Adresse

7 TIMES SQUARE, NEW YORK

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

DNTH's Discussions on Twitter

Vergleichen Sie DNTH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DNTH Dianthus Therapeutics Inc	21.55	689.10M	4.12M	-56.68M	-51.44M	-5.5429
VRTX Vertex Pharmaceuticals Inc	500.19	127.64B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	603.58	65.95B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	656.65	37.92B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	273.55	32.98B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	254.16	26.92B	3.81B	-644.79M	-669.77M	-6.24

Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-20	Eingeleitet	TD Cowen	Buy
2024-10-03	Eingeleitet	Oppenheimer	Outperform
2024-07-26	Eingeleitet	Robert W. Baird	Outperform
2024-06-27	Eingeleitet	Cantor Fitzgerald	Overweight
2024-05-16	Eingeleitet	H.C. Wainwright	Buy
2024-02-15	Eingeleitet	Stifel	Buy
2023-12-26	Eingeleitet	Jefferies	Buy
2023-11-22	Eingeleitet	Wedbush	Outperform
2023-10-30	Eingeleitet	Guggenheim	Buy
2023-09-28	Eingeleitet	Raymond James	Outperform
2022-08-25	Herabstufung	Goldman	Buy → Neutral
2022-01-06	Hochstufung	Goldman	Neutral → Buy
2021-08-20	Fortgesetzt	Goldman	Neutral
2021-08-03	Herabstufung	JP Morgan	Overweight → Neutral
2021-07-22	Bestätigt	B. Riley Securities	Buy
2021-06-29	Eingeleitet	Cantor Fitzgerald	Overweight
2021-06-15	Eingeleitet	BTIG Research	Buy
2021-05-18	Eingeleitet	B. Riley Securities	Buy
2021-01-07	Eingeleitet	Mizuho	Buy
2020-06-08	Hochstufung	Goldman	Neutral → Buy
2019-03-25	Herabstufung	Goldman	Buy → Neutral
2019-03-15	Eingeleitet	Raymond James	Outperform

Alle ansehen

Dianthus Therapeutics Inc Aktie (DNTH) Neueste Nachrichten

07:28 AM

Dianthus Therapeutics completes enrollment for MaGic trial - Investing.com

07:28 AM

07:27 AM

Dianthus Therapeutics completes enrollment for MaGic trial By Investing.com - Investing.com India

07:27 AM

07:00 AM

Breakthrough gMG Treatment DNTH103 Hits Major Milestone: Phase 2 Results Coming This Fall - Stock Titan

07:00 AM

03:29 AM

Invesco Ltd. Purchases 790 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

03:29 AM

12:26 PM

TCG Crossover Management LLC Takes Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

12:26 PM

May 04, 2025

25,000 Shares in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Purchased by Allostery Investments LP - MarketBeat

May 04, 2025

Ally Bridge Group NY LLC Makes New Investment in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

May 04, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Stock Position Lowered by 5AM Venture Management LLC - MarketBeat

May 04, 2025

JPMorgan Chase & Co. Increases Stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

May 04, 2025

Dianthus Therapeutics (DNTH) to Release Quarterly Earnings on Thursday - MarketBeat

May 04, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Shares Gap DownHere's What Happened - MarketBeat

May 04, 2025

May 03, 2025

Analysts Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) PT at $54.33 - MarketBeat

May 03, 2025

May 02, 2025

Adage Capital Partners GP L.L.C. Buys Shares of 180,000 Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

May 02, 2025

May 01, 2025

Legal & General Group Plc Buys 2,363 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

May 01, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 01, 2025

Apr 30, 2025

BlackRock, Inc. Reduces Stake in Dianthus Therapeutics Inc. - GuruFocus

Apr 30, 2025

Apr 29, 2025

Dianthus Therapeutics to Participate in Two Upcoming Investor Events - The Manila Times

Apr 29, 2025

Dianthus Therapeutics Reveals Growth Strategy at Two Elite Healthcare Investment Forums - Stock Titan

Apr 29, 2025

Apr 27, 2025

Dianthus Therapeutics (DNTH) Sees Rise in Short Interest Despite Stock Rebound | DNTH Stock News - GuruFocus

Apr 27, 2025

Apr 26, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 7.4%Time to Buy? - MarketBeat

Apr 26, 2025

Apr 25, 2025

Bain Capital Life Sciences Investors LLC Sells 323,716 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 25, 2025

Apr 24, 2025

Walleye Capital LLC Purchases 52,890 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 24, 2025

Apr 23, 2025

Dianthus Therapeutics: Complement Therapy Developer With Long Road Ahead - Seeking Alpha

Apr 23, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Bought by Geode Capital Management LLC - Defense World

Apr 23, 2025

Apr 21, 2025

Fmr LLC Purchases 36,133 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 21, 2025

Apr 19, 2025

Vanguard Group Inc. Sells 20,331 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 19, 2025

Apr 18, 2025

A stock that deserves closer examination: Dianthus Therapeutics Inc (DNTH) - uspostnews.com

Apr 18, 2025

Apr 14, 2025

Wellington Management Group LLP Boosts Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Apr 14, 2025

Apr 13, 2025

KLP Kapitalforvaltning AS Acquires New Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Apr 13, 2025

Apr 12, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Sold by Corebridge Financial Inc. - Defense World

Apr 12, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Acquired by Alliancebernstein L.P. - MarketBeat

Apr 12, 2025

Apr 11, 2025

ADAR1 Capital Management LLC Sells 101,055 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 11, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by American Century Companies Inc. - Defense World

Apr 11, 2025

Apr 10, 2025

Brokerages Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Target Price at $54.33 - MarketBeat

Apr 10, 2025

Rhenman & Partners Asset Management AB Sells 36,000 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 10, 2025

Apr 09, 2025